As a further demonstration of the reliability of our findings, we created subcutaneous xenograft models and demonstrated that the TGF-β1/FAP/VCAN axis regulates bladder cancer EMT in vivo (Fig. 8; Additional file 9). The gene discussed is VCAN; the disease is urinary bladder carcinoma.